OncoMatch/Clinical Trials/NCT06554652

Selective Neck Dissection Versus Modified Neck Dissection in PTC

Is NCT06554652 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies non-drug interventions for thyroid cancer.

This study is a phase III, randomized controlled, open label non inferiority study. Patients who meet the inclusion criteria are randomly assigned 1:1 to either the experimental group (selective neck dissection) or the control group (modified neck dissection), with LRFS as the primary endpoint. The aim of the study is to evaluate the safety of selective neck dissection in papillary carcinoma with limited number of lymph node metastases in the lateral neck, and the quality of life compared with modified neck dissection.